Pertussis Vaccine Consumption Market Share, Size, Trends & Analysis By Type, Region Insights, Key Players, Applications and Forecast to 2028

  • Category:Pharmaceuticals & Healthcare
  • Published on:Jul 2020
  • Pages:104
  • Formats:
  • Report Code:26382

Report Summary

Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Pertussis Vaccine Consumption market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.

Pertussis Vaccine Consumption market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.

To learn more about this report

Request For Sample

Key Research Highlights: Market Drivers

The Pertussis Vaccine Consumption market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Pertussis Vaccine Consumption products across developed and developing countries of the world.

Key Research Highlights: Market Restrains

Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Pertussis Vaccine Consumption products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Pertussis Vaccine Consumption market.

To learn more about this report

Request For Sample

Key Research Highlights: Trends

Increasing research and development spending on Pertussis Vaccine Consumption development has been the leading industry trend of Pertussis Vaccine Consumption market

The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.

Global Pertussis Vaccine Consumption Market Size, 2018-2028 (USD MILLION)

To learn more about this report

Request For Sample

Market Segmentation

Report Attributes Details
The market size value in 2021 USD XX.XX Million
CAGR (2021 - 2028) XX.XX %
The Revenue forecast in 2028 USD XX.XX Million
Base year for estimation 2021
Historical data 2018-2019
Forecast period 2022-2028
Quantitative units
  • Revenue in USD Million
  • CAGR from 2021 to 2028
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered By Type Outlook, Application Outlook, Regional Outlook
By Type Outlook Whole-cell vaccines,Acellular vaccines, Other
By Application Outlook Children Application,Adults Application, Other
Regional scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Country scope U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey
Key companies profiled Sanofi Pasteur,GSK,Mitsubishi Tanabe Pharma,Astellas Pharma,Minhai Biotechnology,Wuhan Institute of Biological Products,Changchun Changsheng Life Sciences,Other
Customization Available Yes, the report can be tailored to meet your specific requirements.

Key Market Players

  • Sanofi Pasteur
  • GSK
  • Mitsubishi Tanabe Pharma
  • Astellas Pharma
  • Minhai Biotechnology
  • Wuhan Institute of Biological Products
  • Changchun Changsheng Life Sciences
  • Other

Pertussis Vaccine Consumption Market, By Type

  • Whole-cell vaccines
  • Acellular vaccines
  • Other

Pertussis Vaccine Consumption Market, By Application

  • Children Application
  • Adults Application
  • Other

Key Benefits To The Stake Holders

  • Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
  • Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Table Of Contents

Table of Contents

Global Pertussis Vaccine Consumption Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Pertussis Vaccine Consumption Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Whole-cell vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Acellular vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Pertussis Vaccine Consumption Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Pertussis Vaccine Consumption Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Pertussis Vaccine Consumption Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Pertussis Vaccine Consumption Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Pertussis Vaccine Consumption Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Pertussis Vaccine Consumption Market Assessment by Type
8.1 Asia Pacific Pertussis Vaccine Consumption Market Assessment by Application (Consumption and Market Share)
8.2 North America Pertussis Vaccine Consumption Market Assessment by Application (Consumption and Market Share)
8.3 Europe Pertussis Vaccine Consumption Market Assessment by Application (Consumption and Market Share)
8.4 South America Pertussis Vaccine Consumption Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Pertussis Vaccine Consumption Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Sanofi Pasteur
9.1.1 Sanofi Pasteur Profiles
9.1.2 Sanofi Pasteur Product Portfolio
9.1.3 Sanofi Pasteur Pertussis Vaccine Consumption Business Performance
9.1.4 Sanofi Pasteur Pertussis Vaccine Consumption Business Development and Market Status
9.2 GSK
9.2.1 GSK Profiles
9.2.2 GSK Product Portfolio
9.2.3 GSK Pertussis Vaccine Consumption Business Performance
9.2.4 GSK Pertussis Vaccine Consumption Business Development and Market Status
9.3 Mitsubishi Tanabe Pharma
9.3.1 Mitsubishi Tanabe Pharma Profiles
9.3.2 Mitsubishi Tanabe Pharma Product Portfolio
9.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Consumption Business Performance
9.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Consumption Business Development and Market Status
9.4 Astellas Pharma
9.4.1 Astellas Pharma Profiles
9.4.2 Astellas Pharma Product Portfolio
9.4.3 Astellas Pharma Pertussis Vaccine Consumption Business Performance
9.4.4 Astellas Pharma Pertussis Vaccine Consumption Business Development and Market Status
9.5 Minhai Biotechnology
9.5.1 Minhai Biotechnology Profiles
9.5.2 Minhai Biotechnology Product Portfolio
9.5.3 Minhai Biotechnology Pertussis Vaccine Consumption Business Performance
9.5.4 Minhai Biotechnology Pertussis Vaccine Consumption Business Development and Market Status
9.6 Wuhan Institute of Biological Products
9.6.1 Wuhan Institute of Biological Products Profiles
9.6.2 Wuhan Institute of Biological Products Product Portfolio
9.6.3 Wuhan Institute of Biological Products Pertussis Vaccine Consumption Business Performance
9.6.4 Wuhan Institute of Biological Products Pertussis Vaccine Consumption Business Development and Market Status
9.7 Changchun Changsheng Life Sciences
9.7.1 Changchun Changsheng Life Sciences Profiles
9.7.2 Changchun Changsheng Life Sciences Product Portfolio
9.7.3 Changchun Changsheng Life Sciences Pertussis Vaccine Consumption Business Performance
9.7.4 Changchun Changsheng Life Sciences Pertussis Vaccine Consumption Business Development and Market Status
9.8 Other
9.8.1 Other Profiles
9.8.2 Other Product Portfolio
9.8.3 Other Pertussis Vaccine Consumption Business Performance
9.8.4 Other Pertussis Vaccine Consumption Business Development and Market Status
10 World Pertussis Vaccine Consumption Market Assessment by Players
10.1 Global Pertussis Vaccine Consumption Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Pertussis Vaccine Consumption Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Pertussis Vaccine Consumption Price (USD/Unit) of Players 2014-2020
10.4 Global Pertussis Vaccine Consumption Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Pertussis Vaccine Consumption Sales Assessment of Players 2014-2020
11.1.2 North America Pertussis Vaccine Consumption Revenue Assessment of Players 2014-2020
11.1.3 North America Pertussis Vaccine Consumption Price Assessment of Players 2014-2020
11.1.4 North America Pertussis Vaccine Consumption Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Pertussis Vaccine Consumption Sales Assessment of Players 2014-2020
11.2.2 Europe Pertussis Vaccine Consumption Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Pertussis Vaccine Consumption Price Assessment of Players 2014-2020
11.2.4 Europe Pertussis Vaccine Consumption Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Pertussis Vaccine Consumption Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Pertussis Vaccine Consumption Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Pertussis Vaccine Consumption Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Pertussis Vaccine Consumption Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Pertussis Vaccine Consumption Sales Assessment of Players 2014-2020
11.4.2 South America Pertussis Vaccine Consumption Revenue Assessment of Players 2014-2020
11.4.3 South America Pertussis Vaccine Consumption Price Assessment of Players 2014-2020
11.4.4 South America Pertussis Vaccine Consumption Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Pertussis Vaccine Consumption Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Pertussis Vaccine Consumption Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Pertussis Vaccine Consumption Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Pertussis Vaccine Consumption Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Pertussis Vaccine Consumption Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Pertussis Vaccine Consumption Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Pertussis Vaccine Consumption Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Pertussis Vaccine Consumption Sales by Countries/Regions 2014-2020
12.2.2 North America Pertussis Vaccine Consumption Revenue by Countries/Regions 2014-2020
12.2.3 North America Pertussis Vaccine Consumption Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Pertussis Vaccine Consumption Sales by Countries/Regions 2014-2020
12.3.2 Europe Pertussis Vaccine Consumption Revenue by Countries/Regions 2014-2020
12.3.3 Europe Pertussis Vaccine Consumption Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Pertussis Vaccine Consumption Sales by Countries/Regions 2014-2020
12.4.2 South America Pertussis Vaccine Consumption Revenue by Countries/Regions 2014-2020
12.4.3 South America Pertussis Vaccine Consumption Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Pertussis Vaccine Consumption Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Pertussis Vaccine Consumption Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Pertussis Vaccine Consumption Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Pertussis Vaccine Consumption Sales & Revenue Forecast 2021-2026
14.1 World Pertussis Vaccine Consumption Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World Pertussis Vaccine ConsumptionSales and Market Share by Regions
14.1.2 World Pertussis Vaccine ConsumptionRevenue and Market Share by Regions
15 Asia Pertussis Vaccine Consumption Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Whole-cell vaccines
15.1.2 Acellular vaccines
15.2 Consumption Forecast by Application, 2021-2026
16 North America Pertussis Vaccine Consumption Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Whole-cell vaccines
16.1.2 Acellular vaccines
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Pertussis Vaccine Consumption Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Whole-cell vaccines
17.1.2 Acellular vaccines
17.2 Consumption Forecast by Application, 2021-2026
18 South America Pertussis Vaccine Consumption Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Whole-cell vaccines
18.1.2 Acellular vaccines
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Pertussis Vaccine Consumption Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Whole-cell vaccines
19.1.2 Acellular vaccines
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Pertussis Vaccine Consumption Price (USD/Unit) Trend 2021-2026
20.2 Global Pertussis Vaccine Consumption Gross Profit Trend 2021-2026
21 Conclusion


Choose License Type

close

categories